Vitamin B6
BACKGROUND
Vitamin B 6 comprises six compounds – pyridoxal, pyridoxine, pyridoxamine and their respective
5' phosphates (see table below). It acts as a coenzyme in the metabolism of amino acids, glycogen
and sphingoid bases. The most common form in human tissue is the 5'-phosphate form of pyridoxal
(PLP) most of which is found in muscle bound to phosphorylase. The second most common is the
5'-phosphate form of pyridoxamine (PMP). Plant foods contain primarily pyridoxine (PN) and its 5'-
phosphate (PNP), sometimes in the form of a glucoside.
Absorption in the gut involves phosphatase-mediated hydrolysis and transport of the nonphosphorylated
form to the mucosal cells. Quite large doses of PLP and PMP are well absorbed (Hamm
et al 1979). PN glucoside is less well absorbed. Most of the absorbed non-phosphorylated vitamin B 6
goes to the liver where conversion to the phosphorylated form occurs. The major excretory product is
4-pyridoxic acid that accounts for about half the B 6 compounds in urine (Shultz & Leklem 1981).
FORMS AND EQUIVALENCE OF VITAMIN B 6 COMPOUNDS
Units of measurement |
Pyridoxine (PN) | 1g = 5.9 mmol | 1mmol = 170 mg | Three naturally inter-convertible
forms in the tissues |
Pyridoxal (PL) | 1g = 6.0 mmol | 1mmol = 167 mg | |
Pyridoxamine (PM) | 1g = 6.0 mmol | 1mmol = 168 mg | |
Pyridoxal-5-phosphate (PLP) | 1g = 4.1 mmol | 1mmol = 247 mg | Principal active form |
4-Pyridoxic acid (4-PA) | 1g = 5.5 mmol | 1mmol = 183 mg | Principal excretory form |
Pyridoxine hydrochloride (PN.HCl) | 1g = 4.9 mmol | 1mmol = 206 mg | Usual form of supplements |
Vitamin B 6 is found in a wide range of foods including organ meats, muscle meats, breakfast cereals,
vegetables and fruits. Bioavailability is generally in the region of 75% in a mixed diet (Tarr et al 1981).
It has been proposed that vitamin B 6 requirements may be increased at higher protein intake (Baker et
al 1964, Hansen et al 1996a, Linkswiler 1978), although other studies have not shown this (Pannemans
et al 1994). Nevertheless, protein intake is generally taken into consideration in setting requirements for
vitamin B 6 .
Clinical deficiency is rare. The symptoms of deficiency include seborrhaeic dermatitis (Mueller & Vilter
1950), microcytic anaemia (Snyderman et al 1953), convulsions (Bessey et al 1957, Coursin 1954) and
depression and confusion (Hawkins & Barsky 1948).
Indicators used to assess requirements have ranged from measures of vitamin concentrations in plasma,
blood cell or urine to functional measures such as erythrocyte aminotransferase saturation by pyridoxal
5'-phosphate or tryptophan metabolites. Most of these indicators change with dietary intake, but there is
little information about what level would indicate a deficiency state. A review (Lui et al 1985) suggested
that plasma PLP is probably the best single indicator as it reflects tissue stores.
Nutrient Reference Values for Australia and New Zealand. (2006) Published by the Australia Government Dept of Health and Ageing, and the National Health and Medical Research Council. Page: 85
|